Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18932248 | COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID | October 2024 | December 2025 | Allow | 13 | 2 | 0 | No | No |
| 17920483 | AAV NATIVE-NEURO PLATFORM AND USE FOR NEURONAL DISEASE GENE THERAPY | October 2022 | March 2026 | Abandon | 41 | 1 | 0 | No | No |
| 17836266 | ENGINEERED CRISPR/CAS13 SYSTEM AND USES THEREOF | June 2022 | March 2026 | Abandon | 45 | 0 | 1 | No | No |
| 17635036 | INSECT EXTRACELLULAR VESICLES FOR DELIVERY OF NUCLEIC ACIDS | February 2022 | August 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17597997 | NON-VIRAL TRANSGENESIS | February 2022 | January 2026 | Allow | 48 | 1 | 0 | Yes | No |
| 17627040 | HYBRID htiRNA / NANOPARTICLE COMPLEX AND USE THEREOF FOR TREATING A DISEASE OF THE DIGESTIVE SYSTEM | January 2022 | June 2025 | Allow | 41 | 1 | 0 | Yes | No |
| 17620973 | APOLIPOPROTEIN B ANTAGONIST | December 2021 | October 2025 | Abandon | 46 | 0 | 1 | No | No |
| 17517818 | PRODUCTION OF STEVIOL GLYCOSIDES IN RECOMBINANT HOSTS | November 2021 | November 2025 | Abandon | 48 | 0 | 1 | No | No |
| 17309075 | RNA-GUIDED NUCLEASES AND DNA BINDING PROTEINS | April 2021 | February 2025 | Allow | 46 | 2 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner RAVINDRA, KRISHNA NUGGEHALLI works in Art Unit 1636 and has examined 3 patent applications in our dataset. With an allowance rate of 33.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.
Examiner RAVINDRA, KRISHNA NUGGEHALLI's allowance rate of 33.3% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by RAVINDRA, KRISHNA NUGGEHALLI receive 0.67 office actions before reaching final disposition. This places the examiner in the 4% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by RAVINDRA, KRISHNA NUGGEHALLI is 46 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +100.0% benefit to allowance rate for applications examined by RAVINDRA, KRISHNA NUGGEHALLI. This interview benefit is in the 100% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 50.0% of applications are subsequently allowed. This success rate is in the 96% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 1% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.